Patents by Inventor Jorge Blanco

Jorge Blanco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System and semi-supervised methodology for performing machine driven analysis and determination of integrity due diligence risk associated with third party entities and associated individuals and stakeholders
    Patent number: 12235826
    Abstract: Systems and methods for performing machine-driven analysis and determination of integrity due diligence risk associated with third-party entities and individuals associated with third-party entities are disclosed.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: February 25, 2025
    Assignee: KPMG LLP
    Inventors: Pradeep Pai, Bimal Sahay, Anu Sandhu, Jorge Blanco
  • SYSTEM AND SEMI-SUPERVISED METHODOLOGY FOR PERFORMING MACHINE DRIVEN ANALYSIS AND DETERMINATION OF INTEGRITY DUE DILIGENCE RISK ASSOCIATED WITH THIRD PARTY ENTITIES AND ASSOCIATED INDIVIDUALS AND STAKEHOLDERS
    Publication number: 20210026835
    Abstract: Systems and methods for performing machine-driven analysis and determination of integrity due diligence risk associated with third-party entities and individuals associated with third-party entities are disclosed.
    Type: Application
    Filed: July 21, 2020
    Publication date: January 28, 2021
    Inventors: Pradeep PAI, Bimal SAHAY, Anu SANDHU, Jorge BLANCO
  • Use of 5,6-dimethylxanthenone-4-acetic acid as an antiviral agent
    Patent number: 8957108
    Abstract: The invention relates to the areas of therapeutics, pharmaceuticals, drug discovery, and immunotherapy. More specifically, the present invention relates to methods of stimulating the immune system through the administration of flavone acetic acid [FAA] analogs, and in particular, the flavone acetic acid analog, 5,6-dimethylxanthenone-4-acetic acid (DMXAA) so as to comprise an antimicrobial therapeutic agent for the treatment of viral infections of DNA and RNA viruses in humans and non-human animals. The invention is especially suitable for use in a process of treating and preventing infection by, for example, rhinoviruses, enteroviruses, and influenza viruses.
    Type: Grant
    Filed: March 14, 2011
    Date of Patent: February 17, 2015
    Assignee: University of Maryland, Baltimore
    Inventors: Stefanie N. Vogel, Zachary J. Roberts, Jorge Blanco
  • Use of 5,6-Dimethylxanthenone-4-Acetic Acid as an Antiviral Agent
    Publication number: 20110218239
    Abstract: The invention relates to the areas of therapeutics, pharmaceuticals, drug discovery, and immunotherapy. More specifically, the present invention relates to methods of stimulating the immune system through the administration of flavone acetic acid [FAA] analogues, and in particular, the flavone acetic acid analogue, 5,6-dimethylxanthenone-4-acetic acid (DMXAA) so as to comprise an antimicrobial therapeutic agent for the treatment of viral infections of DNA and RNA viruses in humans and non-human animals. The invention is especially suitable for use in a process of treating and preventing infection by, for example, rhinoviruses, enteroviruses, and influenza viruses.
    Type: Application
    Filed: March 14, 2011
    Publication date: September 8, 2011
    Applicant: University of Maryland Baltimore
    Inventors: Stefanie N. Vogel, Zachary J. Roberts, Leah E. Cole, Jorge Blanco